News
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
2don MSN
Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...
Hims & Hers (NYSE: HIMS) and UnitedHealth (NYSE: UNH) suffered huge stock price decreases that attracted investors looking to ...
Hims & Hers' high valuation is no longer justified amid mounting execution and revenue risks. Click here to read why I ...
Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
10don MSN
Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
Hims & Hers Health (NYSE: HIMS) is a telehealth company that offers personalized solutions for its customers. And demand has been robust, with subscriptions for its products rising significantly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results